Bharat Biotech gets emergency use authorisation for intranasal COVID-19 vaccine

Share

Tweet

Share

Share

Email

Comments

Bharat Biotech International Ltd (BBIL) on Tuesday got emergency use authorisation from DCGI for intranasal COVID-19 vaccine, announced Union Health Minister Mansukh mandaviya.

This will be India’s first nasal vaccine for COVID

Bharat Biotech gets emergency use authorisation from DCGI for intranasal #COVID19 vaccine: Union Health Minister Dr Mansukh Mandaviya

This will be India's first nasal vaccine for COVID pic.twitter.com/LZDoVwa5bI

— ANI (@ANI) September 6, 2022